Position Statement by Experts of the Polish Menopause and Andropause Society on menopausal hormone therapy with an oral combination drug containing oestradiol 1 mg and progesterone 100 mg

At a meeting held on 20 May 2021, reviewed the available literature on the use of the medicinal product Bijuva® for the relief of menopausal symptoms.

Detalles Bibliográficos
Autores principales: Bińkowska, Małgorzata, Jakiel, Grzegorz, Paszkowski, Tomasz, Skrzypulec-Plinta, Violetta, Zgliczyński, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Featured Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525257/
https://www.ncbi.nlm.nih.gov/pubmed/34703410
http://dx.doi.org/10.5114/pm.2021.109887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525257/
https://www.ncbi.nlm.nih.gov/pubmed/34703410
http://dx.doi.org/10.5114/pm.2021.109887

Ejemplares similares